NCT05973188View on ClinicalTrials.gov

Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial

PHASE4UnknownINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Left Ventricular Thrombus
Interventions
DRUG

Warfarin

Anticoagulant

DRUG

Rivaroxaban 20 MG Oral Tablet

Anticoagulant

DRUG

Apixaban 5mg or 2.5mg oral tablet

Anticoagulant

Trial Locations (1)

25000

RECRUITING

Peshawar Institute of Cardiology, Peshawar

Sponsors

Collaborators (1)

Getz Pharma
All Listed Sponsors
collaborator

Getz Pharma

INDUSTRY

lead

Peshawar Institute of Cardiology

OTHER_GOV